Farrerol attenuates MPP+ -induced inflammatory response by TLR4 signaling in a microglia cell line

Interleukin-1β, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-α levels in CSF and serum in relation to the clinical diversity of Parkinson’s disease

(2018) M.N. Karpenko et al.   CELLULAR IMMUNOLOGY

Farrerol Relieve Lipopolysaccharide (LPS)-Induced Mastitis by Inhibiting AKT/NF-κB p65, ERK1/2 and P38 Signaling Pathway

(2018) Yanwei Li et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The Potential Role of Toll-Like Receptor 4 in Mediating Dopaminergic Cell Loss and Alpha-Synuclein Expression in the Acute MPTP Mouse Model of Parkinson’s Disease

(2018) Giuseppina Mariucci et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson’s disease

(2017) Joanna Schwenkgrub et al.   PLoS One

Farrerol inhibits IL-6 and IL-8 production in LPS-stimulated human gingival fibroblasts by suppressing PI3K/AKT/NF-κB signaling pathway

(2016) Qian Wang et al.   ARCHIVES OF ORAL BIOLOGY

Inflammatory Process in Alzheimer's and Parkinson's Diseases: Central Role of Cytokines

(2016) Qamre Alam et al.   CURRENT PHARMACEUTICAL DESIGN

6,8-Di-C-methyl-flavonoids with neuroprotective activities from Rhododendron fortunei

(2016) Yongji Lai et al.   FITOTERAPIA

Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease

(2016) Xiao-Yan Qin et al.   JAMA Neurology

TLR4 Signaling in MPP+-Induced Activation of BV-2 Cells

(2016) Peng Zhou et al.   NEURAL PLASTICITY

The antioxidative potential of farrerol occurs via the activation of Nrf2 mediated HO-1 signaling in RAW 264.7 cells

(2015) Xinxin Ci et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Apoptosis induced by farrerol in human gastric cancer SGC-7901 cells through the mitochondrial-mediated pathway

(2015) Enli Liu et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Anti-inflammatory effects of farrerol on IL-1β-stimulated human osteoarthritis chondrocytes

(2015) Hongfei Zhang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Acacia ferrugineainhibits inflammation by regulating inflammatory iNOS and COX-2

(2015) Kunnathur Murugesan Sakthivel et al.   Journal of Immunotoxicology

Inflammation is genetically implicated in Parkinson’s disease

(2015) N. Dzamko et al.   NEUROSCIENCE

Insights into Neuroinflammation in Parkinson’s Disease: From Biomarkers to Anti-Inflammatory Based Therapies

(2015) Natália Pessoa Rocha et al.   Biomed Research International

A Comparative Review of Toll-Like Receptor 4 Expression and Functionality in Different Animal Species

(2014) Céline Vaure et al.   Frontiers in Immunology

NF-κB activity is inversely correlated to RNF11 expression in Parkinson's disease

(2013) Elaine Pranski et al.   NEUROSCIENCE LETTERS

Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease

(2013) Carmen Noelker et al.   Scientific Reports

Colonic inflammation in Parkinson's disease

(2012) David Devos et al.   NEUROBIOLOGY OF DISEASE

A Progressive Mouse Model of Parkinson’s Disease: The Thy1-aSyn (“Line 61”) Mice

(2012) Marie-Francoise Chesselet et al.   Neurotherapeutics

Different Effects of Farrerol on an OVA-Induced Allergic Asthma and LPS-induced Acute Lung Injury

(2012) Xinxin Ci et al.   PLoS One

Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease

(2011) Kozue Kubo et al.   BRAIN RESEARCH

Glia: Initiators and progressors of pathology in Parkinson's disease

(2011) Glenda M. Halliday et al.   MOVEMENT DISORDERS

Neurodegeneration and Inflammation in Parkinson's disease

(2011) Sudarshan Phani et al.   PARKINSONISM & RELATED DISORDERS

The influence of microglia on the pathogenesis of Parkinson's disease

(2009) Caitríona M. Long-Smith et al.   PROGRESS IN NEUROBIOLOGY